enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. Bausch + Lomb is also in the process of seeking regulatory approvals for ...
Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the ...